Company: LHI
Filing Date: 2025-02-14
Form Type: DRS/A
Source: 0001213900-25-014190
Chunk: 299

Company: Living Homeopathy International Ltd.
Filing Date: 2025-02-14
Form: DRS/A
Chunk 299
---
| Total liabilities and shareholders’ equity                                                              |     | $             | 1,001 |     | $         | 1,001 |

| * | Retrospectively restated                         
 for effect of share reorganization (see Note 1). |

| (i) | Basis of preparation |

The Company was incorporated under the laws
of the Cayman Islands as a limited company on May 7, 2024 and as a holding company.

In the condensed parent company only financial
statements, the Company’s investment in subsidiary stated at cost of acquisition in Living Global. Those condensed parent company
only financial statements should be read in connection with the consolidated financial statements and notes hereto.

| (ii) | Restricted net assets |

Schedule I of Rule 5-04 of Regulation S-X
requires the condensed financial information of registrant shall be filed when the restricted net assets of consolidated subsidiaries
exceed 25 percent of consolidated net assets as of the end of the most recently completed fiscal year. For purposes of the above test,
restricted net assets of consolidated subsidiaries shall mean that amount of the registrant’s proportionate share of net assets
of consolidated subsidiaries (after intercompany eliminations) which as of the end of the most recent fiscal year may not be transferred
to the parent company by subsidiaries in the form of loans, advances or cash dividends without the consent of a third party (i.e., lender,
regulatory agency, foreign government, etc.).

The condensed parent company only financial
statements have to be prepared in accordance with Rule 12-04, Schedule I of Regulation S-X if the restricted net assets of the subsidiaries
of Living Homeopathy International Limited exceed 25% of the consolidated net assets of Living Homeopathy International Limited. The
Company generates revenues from its wholly owned subsidiary in Hong Kong. The ability of Living Homeopathy Limited in Hong Kong to pay
dividends is not restricted. In this connection, the restricted net assets of the subsidiaries of Living Homeopathy International Limited
do not exceed 25% of the consolidated net assets of Living Homeopathy International Limited and accordingly the above condensed parent
company only financial information of Living Homeopathy International Limited is presented for supplementary reference.

As of September 30, 2024 and March 31, 2024,
there were no material contingencies, significant provisions of long-term obligations, mandatory dividend or redemption requirements
of redeemable stock or guarantees of the Company, except for those that have been separately disclosed in the consolidated financial
statements, if any.